...
The problem:
The quality and quantity of evidence required to deem a product fit-for-purpose are not agreed upon by industry, patient, or government stakeholders. Currently, there is no consensus on what constitutes “evidence' or what metrics should be used to distinguish high-quality evidence from low-quality evidence.
...